What is Aicardi Syndrome

Aicardi syndrome is a rare genetic disorder characterized by the partial or complete absence of the corpus callosum, distinctive retinal abnormalities, and infantile spasms. It primarily affects females and is considered a neurodevelopmental condition that requires multidisciplinary clinical management.

What are the primary symptoms of Aicardi syndrome?

Aicardi syndrome manifests through a classic triad of symptoms: agenesis of the corpus callosum (the bridge of nerve fibers connecting the brain's hemispheres), chorioretinal lacunae (specific lesions on the retina), and infantile spasms, which are a form of seizure. Beyond these, individuals with Aicardi syndrome may experience developmental delays, intellectual disability, microcephaly, and various skeletal abnormalities, such as rib deformities or vertebral anomalies.

What causes Aicardi syndrome?

The exact genetic cause of Aicardi syndrome remains a subject of ongoing research. It is believed to be caused by a de novo mutation on the X chromosome. Because the condition is almost exclusively seen in females, it is hypothesized that the underlying mutation is lethal to males in utero. The pathology of Aicardi syndrome involves disrupted brain development during the first trimester, leading to the structural brain differences characteristic of the condition.

How rare is Aicardi syndrome?

Aicardi syndrome is an exceptionally rare condition. While precise global prevalence figures are difficult to determine due to underdiagnosis, it is estimated to affect approximately 1 in 100,000 to 250,000 individuals. Currently, 13 people with Aicardi syndrome have joined the DiseaseMaps.org community to share their experiences and support one another.

Key features of Aicardi syndrome

• Gender distribution: Almost exclusively affects females.


• Age of onset: Infantile spasms typically begin between the ages of 2 and 5 months.


• Diagnostic triad: Corpus callosum agenesis, chorioretinal lacunae, and seizures.


• Genetic basis: Most cases occur sporadically (de novo), not through inheritance from parents.

Next steps

• Consult with a pediatric neurologist or a specialist in neurogenetics for a formal evaluation.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by Aicardi syndrome.


• Discuss early intervention therapies, including physical, occupational, and speech therapy, to support developmental milestones.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Aicardi Syndrome


• Orphanet: Rare Disease Database (ORPHA:36)


• Online Mendelian Inheritance in Man (OMIM): #304050 (Aicardi Syndrome)


• Aicardi Syndrome Foundation